Both human and mouse cytomegaloviruses (HCMV and MCMV) avoid peptide presentation through the major histocompatibility complex (MHC) class I pathway to CD8؉ T cells. Within the MHC class I pathway, the vast majority of antigenic peptides are generated by the proteasome system, a multicatalytic protease complex consisting of constitutive subunits, three of which can be replaced by enzymatically active gamma interferon (IFN-␥)-inducible subunits, i.e., LMP2, LMP7, and MECL1, to form the so-called immunoproteasomes. Here, we show that steady-state levels of immunoproteasomes are readily formed in response to MCMV infection in the liver. In contrast, the incorporation of immunoproteasome subunits was prevented in MCMVinfected, as well as HCMV-infected, fibroblasts in vitro. Likewise, the expression of the IFN-␥-inducible proteasome regulator PA28␣ was also impaired in MCMV-infected cells. Both MCMV and HCMV did not alter the constitutive-subunit composition of proteasomes in infected cells. Quantitative assessment of LMP2, MECL1, and LMP7 transcripts revealed that the inhibition of immunoproteasome formation occurred at a pretranscriptional level. Remarkably, a targeted deletion of the MCMV gene M27, encoding an inhibitor of STAT2 that disrupts IFN-␥ receptor signaling, largely restored transcription and protein expression of immunoproteasome subunits in infected cells. While CMV block peptide transport and MHC class I assembly by posttranslational strategies, immunoproteasome assembly, and thus the repertoire of proteasomal peptides, is controlled by pretranscriptional mechanisms. We hypothesize that the blockade of immunoproteasome formation has considerable consequences for shaping the CD8 ؉ -T-cell repertoire during the effector phase of the immune response.Human cytomegalovirus (HCMV), a prototype member of the betaherpesvirus subfamily, is an important pathogen and can cause a wide range of disease manifestations. Primary infection in the immunocompetent host is usually asymptomatic, whereas in the immunocompromised host infection or virus reactivation from latency can cause severe and even fatal disease. Mouse cytomegalovirus (MCMV) shows a similar pathobiology and has a collinear genome (47). Studies of humans and of the mouse have revealed that virus-specific CD8 ϩ T lymphocytes represent the dominant effector arm of protective immunity. For immune recognition, the infected cells present virus-derived peptides on their major histocompatibility complex (MHC) class I molecules to CD8 ϩ cytotoxic T lymphocytes. The processing and presentation of viral peptides is therefore the basis for immune recognition of infected cells, and a change in or lack of peptide supply can undermine the efficiency of T-cell recognition and result in immune evasion of the virus. Both HCMV and MCMV avoid peptide presentation by the expression of several viral glycoproteins (gps) controlling distinct checkpoints of the MHC class I presentation pathway. Specifically, the HCMV US6-encoded gp shuts off the translocation of peptides acr...